Careers Media center Contacts

Rosuvastatin – a generic cholesterol control medicine

Rosuvastatin – a generic cholesterol control medicine

2 March 2020 | News

This January in Ukraine Arterium Corporation launched the generic medicine Rosuvastatin*, which is used in the comprehensive treatment of cardiovascular diseases (CVD).

Rosuvastatin belongs to a group of statins which are cholesterol-lowering drugs. Cholesterol is associated with the development of myocardial infarctions and strokes. By controlling cholesterol levels, Rosuvastatin can reduce the occurrence of such conditions and so increase life expectancy. Rosuvastatin is included in international guidelines for the treatment of coronary heart disease, of which the most common is CVD. The number of patients in Ukraine who regularly take statins is very low. Price factor plays an important role in this. The introduction of the new quality generic medicine Rosuvastatin from Arterium Corporation is our contribution to the health of Ukrainians.

* The generic medicine Rosuvastatin is manufactured by Biopharm Ltd., Poland, under a commercial agreement. Arterium Corporation's own Rosuvastatin is now in the final stages of development.

Media gallery

Here you can find general information about the company intended for journalists and other stakeholders


For all media-related enquiries,
please contact us
mob.: +38050 446 71 20, +38095 278 92 80